VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CCM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CCMConcord Medical Services Holdings Limited
$4.58$666917
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

CCM logoConcord Medical Services Holdings Limited(CCM)Earnings, Financials & Key Ratios

CCM•NYSE
$4.58
Price updated Jul 6, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustrySpecialty chronic care clinics
AboutConcord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, and diagnostic imaging services. The company's other treatments and diagnostic services comprise computed tomography scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2021, it operated a network of 16 cooperative centers based in 13 hospitals. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the People's Republic of China.Show more
  • Revenue$461M+19.9%
  • EBITDA-$90M+77.6%
  • Net Income-$93M+69.9%
  • EPS (Diluted)-621.00+70.7%
  • Gross Margin5.61%+127.2%
  • EBITDA Margin-19.56%+81.3%
  • Operating Margin-51.97%+62.5%
  • Net Margin-20.15%+74.9%
  • ROE-5.35%+70.8%

CCM Price & Volume

Concord Medical Services Holdings Limited (CCM) stock price & volume — 10-year historical chart

Loading chart...

Persistent Operational Losses Threaten Long-term Solvency

Investment Thesis • Updated 2025Q2

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Regulatory and Solvency Risk

Key Thesis Takeaways

  • Concord Medical Services faces a precarious outlook characterized by a sustained 8.3% year-over-year revenue contraction and a deeply negative operating margin of -72.1% as of 2025Q2.
  • The company's reliance on $3.8 billion in debt against a negative $2.2 billion equity position suggests significant insolvency risk and a lack of operational viability.
  • Investors should remain cautious as the absence of capital expenditure and persistent net losses indicate a fundamental inability to maintain its radiotherapy asset base.

Verdict Logic

the company's negative $2.2 billion equity position and persistent inability to generate positive operating cash flow present an unacceptable risk profile for institutional investors.

CCM Growth Metrics

Concord Medical Services Holdings Limited (CCM) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-2.87%
5 Years15.61%
3 Years-0.82%
TTM-22.46%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM56.95%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM56.71%

Return on Capital

10 Years-9.25%
5 Years-9.37%
3 Years-9.25%
Last Year-5.21%

Latest CCM News

Recent stock market news and headlines for Concord Medical Services Holdings Limited (CCM)

Business Wire·Jun 22, 2026
TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO's Stock Price

NEW YORK--(BUSINESS WIRE)--TWO Urges Stockholders to Vote FOR the CCM Transaction Today; Failure to Approve Risks a Significant Decline in TWO's Stock Price.

Peers Comparison

Key metrics vs top competitors for Concord Medical Services Holdings Limited (CCM)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
CCM logoCCMConcord Medical Services Holdings LimitedCurrent
$4.58$666.92K-0.0519.94%-20.15%-5.35%—
RDNT logoRDNTRadNet, Inc.
$68.92$5.42B-275.6811.51%-0.66%-1.09%—
USPH logoUSPHU.S. Physical Therapy, Inc.
$73.38$1.12B51.6816.33%1.52%1.36%—
AMSF logoAMSFAMERISAFE, Inc.
$34.65$651.24M14.032.63%14.27%9.68%—
ARAY logoARAYAccuray Incorporated
$0.27$32.24M-17.482.68%-10.76%-77.48%—
MLAB logoMLABMesa Laboratories, Inc.
$102.56$566.64M84.763.38%2.69%3.71%—

Compare CCM vs Peers

Concord Medical Services Holdings Limited (CCM) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs RDNT

Most directly comparable listed peer for CCM.

Scale Benchmark

vs ISRG

Larger-name benchmark to compare CCM against a more recognizable public peer.

Peer Set

Compare Top 5

vs RDNT, USPH, AMSF, ARAY

Get notified when CCM posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CCM Frequently Asked Questions

Concord Medical Services Holdings Limited (CCM) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Concord Medical Services Holdings Limited's revenue?

Concord Medical Services Holdings Limited (CCM) reported $365.8M in revenue for fiscal year 2025. This represents a 113% increase from $171.8M in 2008.

How fast is Concord Medical Services Holdings Limited growing?

Concord Medical Services Holdings Limited (CCM) grew revenue by 19.9% over the past year. This is strong growth.

Is CCM profitable?

Concord Medical Services Holdings Limited (CCM) reported a net loss of $163.1M for fiscal year 2025.

Dividend & Returns
What is CCM's return on equity?

Concord Medical Services Holdings Limited (CCM) has a return on equity (ROE) of -5.4%. Negative ROE indicates the company is unprofitable.

What is Concord Medical Services Holdings Limited's free cash flow?

Concord Medical Services Holdings Limited (CCM) had negative free cash flow of $293.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CCM back in 2008?

Total return calculator · dividends reinvested · 18+ years of data

See returns →